Distinguished in Congenital Hyperinsulinism

Dr. Jack A. Yanovski

Pediatric Endocrinology
10 Center Dr, Nih Hatfield Crc, Rm 1e-3330 Msc 1103, 
Bethesda, MD 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Congenital Hyperinsulinism
10 Center Dr, Nih Hatfield Crc, Rm 1e-3330 Msc 1103, 
Bethesda, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jack Yanovski is a Pediatric Endocrinologist in Bethesda, Maryland. Dr. Yanovski is rated as a Distinguished provider by MediFind in the treatment of Congenital Hyperinsulinism. His top areas of expertise are Obesity, Obesity in Children, Congenital Hyperinsulinism, and Prader-Willi Syndrome.

His clinical research consists of co-authoring 225 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 21 articles in the study of Congenital Hyperinsulinism.

Specialties
Pediatric Endocrinology
Licenses
Pediatric Endocrinology in MD
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

10 Center Dr, Nih Hatfield Crc, Rm 1e-3330 Msc 1103, Bethesda, MD 20892

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Children's Growth and Behavior Study
Children's Growth and Behavior Study
Enrollment Status: Recruiting
Publish Date: September 30, 2025
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
View 3 Less Clinical Trials

225 Total Publications

The Effect of Experimentally Induced Cognitive Fatigue on Energy Intake Among Youth With and Without Recent Reported Dietary Restraint.
The Effect of Experimentally Induced Cognitive Fatigue on Energy Intake Among Youth With and Without Recent Reported Dietary Restraint.
Journal: The International journal of eating disorders
Published: May 15, 2025
Similar Doctors
Advanced in Congenital Hyperinsulinism
Dr. Sheela Magge
Pediatric Endocrinology
Advanced in Congenital Hyperinsulinism
Dr. Sheela Magge
Pediatric Endocrinology
600 N Wolfe St, 
Baltimore, MD 
 (34.2 miles away)
410-955-9441
Languages Spoken:
English
See accepted insurances

Sheela Magge is a Pediatric Endocrinologist in Baltimore, Maryland. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Obesity, Congenital Hyperinsulinism, Type 2 Diabetes (T2D), and Obesity in Children.

Advanced in Congenital Hyperinsulinism
Dr. Neha Vyas
Pediatric Endocrinology
Advanced in Congenital Hyperinsulinism
Dr. Neha Vyas
Pediatric Endocrinology
2411 W Belvedere Ave, Suite 205, 
Baltimore, MD 
 (33.8 miles away)
410-601-8331
Languages Spoken:
English
See accepted insurances

Neha Vyas is a Pediatric Endocrinologist in Baltimore, Maryland. Dr. Vyas is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Precocious Puberty, and Familial Short Stature (FSS).

Experienced in Congenital Hyperinsulinism
Dr. Miranda M. Broadney
Pediatric Endocrinology | Pediatrics
Experienced in Congenital Hyperinsulinism
Dr. Miranda M. Broadney
Pediatric Endocrinology | Pediatrics
827 Linden Ave, 
Baltimore, MD 
 (33.0 miles away)
410-225-8780
Languages Spoken:
English

Miranda Broadney is a Pediatric Endocrinologist and a Pediatrics provider in Baltimore, Maryland. Dr. Broadney is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Obesity, Congenital Hyperinsulinism, and Obesity in Children.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yanovski's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile